TWEAK appears as a modulator of endometrial IL-18 related cytotoxic activity of uterine natural killers.
<h4>Background</h4>TWEAK (Tumor necrosis factor like WEAK inducer of apoptosis) is highly expressed by different immune cells and triggers multiple cellular responses, including control of angiogenesis. Our objective was to investigate its role in the human endometrium during the implant...
Guardado en:
Autores principales: | Marie Petitbarat, Mona Rahmati, Valérie Sérazin, Sylvie Dubanchet, Corinne Morvan, Robert Wainer, Philippe de Mazancourt, Gérard Chaouat, Jean-Michel Foidart, Carine Munaut, Nathalie Lédée |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5705640e236f4589842bfc1a521a9b7d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Granulocyte-Colony Stimulating Factor related pathways tested on an endometrial ex-vivo model.
por: Mona Rahmati, et al.
Publicado: (2014) -
Endometrial exosomes/microvesicles in the uterine microenvironment: a new paradigm for embryo-endometrial cross talk at implantation.
por: York Hunt Ng, et al.
Publicado: (2013) -
Rate of premalignant and malignant endometrial lesion in “low-risk” premenopausal women with abnormal uterine bleeding undergoing endometrial biopsy
por: Sangam Jha, et al.
Publicado: (2021) -
mSphere of Influence: Tweaking Organellar Purification Approaches
por: Diego Huet
Publicado: (2020) -
TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis
por: Daniel Sidler, et al.
Publicado: (2017)